Phoenix Innovative Healthcare Manufacturers Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 04-10-2024
- Paid Up Capital ₹ 0.10 M
as on 04-10-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 42.37%
(FY 2023)
- Profit 195.31%
(FY 2023)
- Ebitda 2614.60%
(FY 2023)
- Net Worth 12.98%
(FY 2023)
- Total Assets 14.92%
(FY 2023)
About Phoenix Innovative Healthcare Manufacturers
The Corporate was formerly known as Phoenix Innovative Medical Manufacturer Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Juan Rodriguez, Arun Singh, Prasad Jambavdekar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900MH2013PTC249783
- Company No.
249783
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Phoenix Innovative Healthcare Manufacturers?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Juan Rodriguez  | Director | 11-Aug-2014 | Current |
Arun Singh  | Director | 27-Aug-2018 | Current |
| Prasad Jambavdekar | Additional Director | 13-Mar-2024 | Current |
| Manuel Aguero | Director | 11-Aug-2014 | Current |
Financial Performance of Phoenix Innovative Healthcare Manufacturers.
Phoenix Innovative Healthcare Manufacturers Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.37% increase. The company also saw a substantial improvement in profitability, with a 195.31% increase in profit. The company's net worth Soared by an impressive increase of 12.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phoenix Innovative Healthcare Manufacturers?
In 2023, Phoenix Innovative Healthcare Manufacturers had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phoenix Innovative Healthcare Manufacturers?
Phoenix Innovative Healthcare Manufacturers has a workforce of 216 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phoenix Innovative Healthcare Manufacturers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Innovative Healthcare Manufacturers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
